Stockscreener 앱 받기
20.51
1.11%
-0.23
시간 외 거래:
20.50
-0.01
-0.05%
Structure Therapeutics Inc Adr 주식(GPCR)의 최신 뉴스
Data-Based Insights About Structure Therapeutics Inc ADR (GPCR) - Stocksregister
Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarkets™METRO - METRO - NEWS CHANNEL NEBRASKA
Cantor Fitzgerald Comments on GPCR FY2026 Earnings - Defense World
Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarketsNORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA
Cantor Fitzgerald Estimates GPCR FY2025 Earnings - Defense World
Oral Proteins and Peptides Market Report Latest Trends and Future Opportunities Analysis - openPR.com
Structure Therapeutics Inc. (NASDAQ:GPCR) Given Average Recommendation of “Buy” by Brokerages - Defense World
Structure Therapeutics, Inc.: Catalyst-Rich Outlook and Strategic Preparations Support Buy Rating - TipRanks
Bank of America Corp DE Has $1.47 Million Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
GLP-1 Receptor Agonists: The Surge of M&A Activity and the Future of Metabolic Health - The National Law Review
Structure Therapeutics Set for Jefferies and Goldman Sachs Healthcare Conference Presentations in June - Stock Titan
Telomir Pharmaceuticals Confirms Telomir-1 Restores Vision and Retinal Structure in Age-Related Macular Degeneration (AMD) Animal Model Using FDA-Recognized Surrogate Endpoints - standard-journal.com
BNP Paribas Financial Markets Increases Stake in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
BNP Paribas Financial Markets Makes New $304,000 Investment in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
Analysts Have Conflicting Sentiments on These Healthcare Companies: Novo Nordisk (NVO), Beam Therapeutics (BEAM) and TScan Therapeutics (TCRX) - The Globe and Mail
Structure Therapeutics’ SWOT analysis: oral obesity drug stock poised for growth - Investing.com
Analysts Set Structure Therapeutics Inc. (NASDAQ:GPCR) Target Price at $78.00 - Defense World
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Relmada Therapeutics (RLMD) and Roivant Sciences (ROIV) - The Globe and Mail
Structure Therapeutics (NASDAQ:GPCR) Price Target Lowered to $75.00 at HC Wainwright - Defense World
FY2025 Earnings Forecast for GPCR Issued By Leerink Partnrs - Defense World
Envestnet Asset Management Inc. Has $201,000 Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
Tower Research Capital LLC TRC Acquires 3,549 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - The AM Reporter
Structure Therapeutics Reports Increased Losses Amid Rising R&D Costs - TipRanks
Structure Therapeutics Reports First Quarter 2025 Financial Results and Recent Highlights - Stock Titan
Wells Fargo & Company MN Boosts Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
Analyzing Ratios: Structure Therapeutics Inc ADR (GPCR)’s Financial Story Unveiled - DWinneX
Analysts Offer Insights on Healthcare Companies: Guardant Health (GH), AnaptysBio (ANAB) and Alignment Healthcare (ALHC) - The Globe and Mail
Structure Therapeutics Inc ADR (NASDAQ: GPCR) Is Up 1.57% So Far This Year: What Will Happen Next? - Stocksregister
Structure Therapeutics (NASDAQ:GPCR) Research Coverage Started at Citigroup - Defense World
Structure Therapeutics Inc ADR (GPCR) expanding its growth trajectory ahead - Sete News
Buy Recommendation for Structure Therapeutics: Promising Pipeline and Obesity Treatment Market Potential - TipRanks
Citi sets Structure Therapeutics stock Buy rating, $60 target By Investing.com - Investing.com India
Technical analysis of Stoke Therapeutics Inc (STOK) stock chart patterns - uspostnews.com
Terns Pharmaceuticals Inc (TERN) deserves deeper analysis - uspostnews.com
A stock that deserves closer examination: Structure Therapeutics Inc ADR (GPCR) - uspostnews.com
What is the investor’s view on LSB Industries, Inc (LXU)? - uspostnews.com
Geode Capital Management LLC Increases Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
Pfizer eyes smaller drugmakers after failure of obesity pill - medwatch.com
The Potential Rise in the Price of Structure Therapeutics Inc ADR (GPCR) following insiders activity - knoxdaily.com
A Guide To The Risks Of Investing In Jamf Holding Corp (JAMF) - knoxdaily.com
GPCR Stock: A Voyage Through Structure Therapeutics Inc ADR’s Finances - investchronicle.com
Recent Insider Activity Could Benefit Pacific Premier Bancorp, Inc (PPBI) - knoxdaily.com
Barclays PLC Increases Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
24,530 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Acquired by Mariner LLC - Defense World
Market Update: CytomX Therapeutics Inc (CTMX) Sees Negative Movement, Closing at 0.71 - DWinneX
Stock Market Recap: Barrick Gold Corp (GOLD) Concludes at 19.30, a 1.31 Surge/Decline - DWinneX
Market Resilience: ReShape Lifesciences Inc (RSLS) Finishes Weak at 0.36, Down -0.85 - DWinneX
Gaining Ground: Structure Therapeutics Inc ADR (GPCR) Closes Lower at 23.62, Down -0.51 - DWinneX
JPMorgan Chase & Co. Has $876,000 Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
Structure Therapeutics Inc. (NASDAQ:GPCR) Shares Acquired by LPL Financial LLC - Defense World
LPL Financial LLC Has $341,000 Stock Holdings in AdvisorShares Dorsey Wright FSM All Cap World ETF (NASDAQ:DWAW) - American Banking and Market News
Is Structure Therapeutics Inc. (NASDAQ:GPCR) the Most Promising Small-Cap Stock According to Analysts? - Yahoo Finance
Is Edgewise Therapeutics Inc. (NASDAQ:EWTX) the Most Promising Small-Cap Stock According to Analysts? - Yahoo Finance
Structure Therapeutics’ (GPCR) “Buy” Rating Reiterated at HC Wainwright - Defense World
Daily Progress: Structure Therapeutics Inc ADR (GPCR) Drop -11.51, Closing at 21.03 - DWinneX
Structure Therapeutics Inc. (NASDAQ:GPCR) Given Consensus Rating of “Buy” by Analysts - The AM Reporter
Metric Analysis: Silvercorp Metals Inc (SVM)’s Key Ratios in the Limelight - DWinneX
Ratios Revealed: Decoding Structure Therapeutics Inc ADR (GPCR)’s Financial Health - DWinneX
Invesco Ltd. Grows Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
0.39%
0.42%
자본화:
|
볼륨(24시간):